The Scientist in the New Millennium

Those who have read The Scientist for more than a few years have witnessed changes both great and small in the publication. The change from newsprint to glossy paper, the introduction of controlled unpaid circulation to qualified life scientists, and the increased focus on life scientists can all be counted as major changes. With this issue, we are introducing a new look to The Scientist, in both size and design. Our page size is now two inches shorter than previously, making a more compa

Written byAlexander Grimwade
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Those who have read The Scientist for more than a few years have witnessed changes both great and small in the publication. The change from newsprint to glossy paper, the introduction of controlled unpaid circulation to qualified life scientists, and the increased focus on life scientists can all be counted as major changes.

With this issue, we are introducing a new look to The Scientist, in both size and design. Our page size is now two inches shorter than previously, making a more compact and easily managed publication. Perhaps it will also make library storage more convenient--librarians have long commented on the difficulties of storing tabloid-size publications in shelves designed for standard page sizes.

There are numerous practical and financial reasons for this change: Modern printing presses can more easily and economically handle the smaller size, our advertisers tell us that they like it, and it will lead to less ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies